Phase II Trial of Alfimeprase, a Novel-Acting Fibrin Degradation Agent, for Occluded Central Venous Access Devices

Phase II Trial of Alfimeprase, a Novel-Acting Fibrin Degradation Agent, for Occluded Central Venous Access Devices is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 53 citations, 2006 year and bronze oa status.